Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Conduit Pharmaceuticals Inc CDT

Technology Scientific & Technical Instruments
Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company’s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection... see more

Recent & Breaking News (NDAQ:CDT)

    Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

    GlobeNewswire March 19, 2024

    Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

    GlobeNewswire March 11, 2024

    Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

    GlobeNewswire January 31, 2024

    Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

    GlobeNewswire November 2, 2023

    Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

    GlobeNewswire October 11, 2023

    Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)

    GlobeNewswire October 6, 2023

    Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

    GlobeNewswire September 22, 2023

    Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives 

    GlobeNewswire September 13, 2023

    Murphy Canyon Acquisition Corp. Announces Postponement of Its Special Meeting of Stockholders for Approving Its Initial Business Combination With Conduit

    Accesswire September 7, 2023

    Murphy Canyon Acquisition Corp. Announces Postponement of its Special Meeting of Stockholders for Approving its Initial Business Combination with Conduit

    Accesswire August 31, 2023

    SEC Declares Form S-4 Registration Statement "Effective" for Proposed Business Combination of Murphy Canyon Acquisition Corp. with Conduit Pharmaceuticals Limited

    Accesswire August 16, 2023

    Conduit Pharmaceuticals to Become a Publicly Traded Company via Merger with Murphy Canyon Acquisition Corp.

    Accesswire November 8, 2022